Turkey Androgenetic Alopecia Market Size & Outlook
Turkey androgenetic alopecia market, 2018-2030 (US$M)
Related Markets
Turkey androgenetic alopecia market highlights
- The Turkey androgenetic alopecia market generated a revenue of USD 6.7 million in 2023 and is expected to reach USD 12.3 million by 2030.
- The Turkey market is expected to grow at a CAGR of 9% from 2024 to 2030.
- In terms of segment, pharmaceuticals was the largest revenue generating treatment in 2023.
- Devices is the most lucrative treatment segment registering the fastest growth during the forecast period.
Androgenetic alopecia market data book summary
| Market revenue in 2023 | USD 6.7 million |
| Market revenue in 2030 | USD 12.3 million |
| Growth rate | 9% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceuticals, Devices |
| Key market players worldwide | Johnson & Johnson, Cipla Ltd DR, Sun Pharmaceutical Industries, Merck & Co Inc, Dr. Reddy’s Laboratories, Cardiff Lexington Corp, Amgen Inc, Theradome, Aurobindo Pharma, Curallux, Apira Science |
Other key industry trends
- In terms of revenue, Turkey accounted for 0.2% of the global androgenetic alopecia market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, UAE androgenetic alopecia market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 27.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Androgenetic Alopecia Market Scope
Androgenetic Alopecia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Turkey androgenetic alopecia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to androgenetic alopecia market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Turkey androgenetic alopecia market based on pharmaceuticals, devices covering the revenue growth of each sub-segment from 2018 to 2030.
The improved healthcare infrastructure, growing awareness among people about alopecia, and increasing risk of developing AGA with aging are some of key factors propelling market growth. According to a report published by PubMed in September 2021, the prevalence of AGA in men was 47.6% and in women was 19.17%.
Moreover, the government in Turkey is undertaking favorable initiatives to improve healthcare services and promote health tourism by giving tax rebates and a simplified visa process for medical tourists.
Furthermore, the presence of several service providers offering different therapeutics for hair loss is driving the market growth. Key service providers, such as Turquie Sante, Civas Hair Transplant, Regenera Activa, Este Medical Group Turkey, Vera Clinic, Turkeyana Clinic, and others, are offering laser hair growth therapy, PRP therapy, hormonal therapy, and other products for restoring hair loss.
Reasons to subscribe to Turkey androgenetic alopecia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Turkey androgenetic alopecia market databook
-
Our clientele includes a mix of androgenetic alopecia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Turkey androgenetic alopecia market , including forecasts for subscribers. This country databook contains high-level insights into Turkey androgenetic alopecia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Turkey androgenetic alopecia market size, by treatment, 2018-2030 (US$M)
Turkey Androgenetic Alopecia Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
